RS
Ravi Shanker Singh
About Ravi Shanker Singh
Data last updated:
Ravi Shanker Singh is a Director at Kwality Pharmaceuticals Limited (since 2016), Director at Herbal Health Research Consortium Private Limited (since 2008) and Director at Shree Dhanwantri Herbals Private Limited (since 2025). The companies operate in Pharma, Healthcare and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹258 Cr; the largest is Kwality Pharmaceuticals Limited at ₹254 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kwality Pharmaceuticals Limited L24232PB1983PLC005426 | Director | 01 Feb 2016 | 1983 | ₹254 Cr (FY 2023) | Active |
 Herbal Health Research Consortium Private Limited U24233PB2008PTC032243 | Director | 29 Aug 2008 | 2008 | ₹3.91 Cr (FY 2025) | Active |
 Shree Dhanwantri Herbals Private Limited U21003HP2025PTC011525 | Director | 21 Mar 2025 | 2025 | Active |
Board colleagues of Ravi Shanker Singh
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Shanker Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Shanker Singh
Ravi Shanker Singh currently holds 3 directorships: Kwality Pharmaceuticals Limited (Director, since 01 Feb 2016, revenue ₹254 Cr (FY 2023)); Herbal Health Research Consortium Private Limited (Director, since 29 Aug 2008, revenue ₹3.91 Cr (FY 2025)); Shree Dhanwantri Herbals Private Limited (Director, since 21 Mar 2025).
Ravi Shanker Singh was first appointed on 29 Aug 2008 as Director at Herbal Health Research Consortium Private Limited. The most recent appointment on record is 21 Mar 2025 at Shree Dhanwantri Herbals Private Limited.
The 2 current companies of Ravi Shanker Singh that report revenue have a combined latest revenue of ₹258 Cr: Kwality Pharmaceuticals Limited ₹254 Cr (FY 2023); Herbal Health Research Consortium Private Limited ₹3.91 Cr (FY 2025).
The current boards of Ravi Shanker Singh's companies include Aditya Arora (Kwality Pharmaceuticals Limited), Aditya Arora (Kwality Pharmaceuticals Limited), Ajay Kumar Arora (Kwality Pharmaceuticals Limited), Anju Arora (Kwality Pharmaceuticals Limited), Bhavesh Mahajan (Kwality Pharmaceuticals Limited), Geeta Arora (Kwality Pharmaceuticals Limited), among others.